Sanofi · 17 hours ago
Senior Director Access Strategy aT1D and CVnM
Cambridge, MA
Full-time
Onsite
Director/Executive
$206K/yr - $298K/yr
10+ years expSanofi is an R&D-driven, AI-powered biopharma company committed to improving people’s lives. The Senior Director, US Access Strategy – aT1D & CV&M will lead a high-impact team responsible for defining and executing US market access strategies for TZIELD and future assets across the aT1D and cardiovascular & metabolic portfolio.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Own the US market access strategy for TZIELD and the aT1D & CV&M portfolio, with accountability for defining short- and long-term pricing, contracting, and payer engagement strategy
Serve as the primary US access and pricing leader for pipeline assets and business development evaluations, shaping portfolio decisions by assessing US access feasibility, reimbursement risk, and pricing potential
Provide strategic leadership and decision-shaping input into market assessments, product positioning, and target product profiles by integrating access, reimbursement, and pricing considerations early and consistently across the product lifecycle
Represent the US access customer perspective within cross-functional and cross-regional commercialization teams (Brand, USMA, HEVA/RWE, Market Access Shared Services, PSS, Trade, Finance, Communications, Policy/Advocacy, and Public Affairs), with accountability for optimizing the lifecycle performance of TZIELD and future assets
Own and oversee Patient Support Services (PSS) marketing, providing strategic direction through direct team leadership and serving as a thought partner to PSS leadership to ensure patient access, affordability, and experience strategies are fully integrated with payer and institutional access objectives
Lead execution of core Market Access deliverables in partnership with Global Market Access and US teams, translating strategy into tools, capabilities, and field-ready resources
Engage directly in key account and stakeholder discussions as appropriate, to communicate brand/portfolio value and evolving market dynamics
As a senior member of the global market access community, ensure strong US input and feedback into Global Value and Access deliverables, including launch readiness, contracting strategy, negotiation preparedness, and innovative access frameworks
Monitor and interpret the evolving US access landscape, identifying emerging trends, risks, and opportunities across diabetes, aT1D, and CV&M, and translating insights into actionable strategy
Lead, develop, and mentor a high-performing access strategy team, fostering strategic thinking, cross-functional influence, and strong execution
Qualification
Required
BA/BS required; 10+ years of experience in US market access, pricing, and reimbursement, with demonstrated ownership of access strategy development and execution for specialty products
Proven strategic leadership experience, including setting access and pricing strategy, influencing senior cross-functional stakeholders, and leading teams or senior individual contributors in complex, matrixed organizations
Deep understanding of the US payer and institutional access landscape, with the ability to assess access feasibility, pricing implications, and reimbursement risk across inline assets and pipeline opportunities
Preferred
Demonstrated success leading in complex, matrixed organizations, with the ability to influence without authority and drive alignment across Global, US, and cross-functional stakeholders to deliver access and commercialization objectives
Proven ability to navigate highly complex, ambiguous business challenges, translating access, pricing, and reimbursement considerations into clear, actionable strategic recommendations for senior leadership
Exceptional communication and relationship-building skills, including experience presenting to and influencing senior executives, and building effective partnerships across functions, geographies, and levels of the organization
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
10001+ employees
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Leadership Team
Paul Hudson
Chief Executive Officer
Francois-Xavier Roger
Chief Financial Officer
Recent News
2026-01-16
Company data provided by crunchbase